FDA Court Loss Shows ‘Disconnect’ Between Old Regulatory Language And Cell Therapy Technology

 
• By Brenda Sandburg
Disconnect maze
The gap between old regulatory langage and new technology is problematic for FDA regulation of stem cell treatments • Source: Shutterstock

More from Legal & IP

More from Pink Sheet